Latigo Biotherapeutics, Inc.: 8-K filed Sep 3, 2026

Form type

8-K

Filing date

Sep 3, 2026

Accession number

0001193125-26-381912

Filer

Latigo Biotherapeutics, Inc. (CIK 2056611)